More Data Back CAR T-Cell Therapy for Lupus, With Promise of Wider Availability

(MedPage Today) — BARCELONA — Chimeric antigen receptor (CAR) T-cell therapy for rheumatologic disease is now expanding out of academe into the commercial space, with encouraging new data reported here from a U.S.-based industry program.
A…